[1] Brunet L, Miranda J, Farre M, et al. Gingival enlargement induced by drugs [J]. Drug safety, 1996, 15(3)∶219-231 [2] Barclay S, Thomason JM, Idle JR, et al. The incidence and severity of nifedipine-induced gingival overgrowth [J]. J Clin Periodontol, 1992,19(5)∶311-314 [3] Subramani T, Rathnavelu V, Alitheen NB. The possible potential therapeutic targets for drug induced gingival overgrowth [J]. Mediators Inflamm, 2013, 2013∶639468 [4] Di CP, Sun Y, Zhao L, et al. Effect of nifedipine on the expression of keratinocyte growth factor and its receptor in cocultured/monocultured fibroblasts and keratinocytes [J]. J Periodontal Res, 2013, 48(6)∶740-747 [5] Subramani T, Senthilkumar K, Periasamy S, et al. Expression of angiotensin Ⅱ and its receptors in cyclosporine-induced gingival overgrowth [J]. J Periodontal Res,2013,48(3)∶386-391 [6] Salman BN, Vahabi S, Movaghar SE, et al. Proliferative and inductive effects of Cyclosporine a on gingival fibroblast of child and adult [J]. Dent Res J (Isfahan),2013,10(1)∶52-58 [7] Parkar MH, Hussain F, Wickramaratna A, et al. The immunosuppressant and hyperplasia-inducing drug cyclosporin A regulates the cell cycle and cyclin B1 gene expression in gingival fibroblasts in vitro [J]. Cell Tissue Res, 2004, 317(2)∶221-225 [8] Nishimura F, Naruishi H, Naruishi K, et al. Cathepsin-L, a key molecule in the pathogenesis of drug-induced and I-cell disease-mediated gingival overgrowth: a study with cathepsin-L-deficient mice [J]. Am J Pathol, 2002, 161(6)∶2047-2052 [9] Correa JD, Queiroz-Junior CM, Costa JE. Phenytoin-induced gingival overgrowth: a review of the molecular, immune, and inflammatory features [J]. ISRN Dent, 2011, 2011∶497850 [10] Arora PD, Glogauer M, Kapus A, et al. Gelsolin mediates collagen phagocytosis through a rac-dependent step [J]. Mol Biol Cell, 2004, 15(2)∶588-599 [11] Gurkan A, Emingil G, Afacan B, et al. Alpha 2 integrin gene (ITGA2) polymorphism in renal transplant recipients with and without drug induced gingival overgrowth [J]. Arch Oral Biol, 2014, 59(3)∶283-288 [12] Kuo PJ, Tu HP, Chin YT, et al. Cyclosporine-A inhibits MMP-2 and -9 activities in the presence of porphyromonas gingivalis lipopolysaccharide: an experiment in human gingival fibroblast and U937 macrophage co-culture [J]. J Periodontal Res, 2012, 47(4)∶431-438 [13] Kanno CM, Oliveira JA, Garcia JF, et al. Effects of cyclosporin, phenytoin, and nifedipine on the synthesis and degradation of gingival collagen in tufted capuchin monkeys (Cebus apella): histochemical and MMP-1 and -2 and collagen I gene expression analyses [J]. J Periodontol, 2008, 79(1)∶114-122 [14] Xin X, Hou YT, Li L, et al. IGF-I increases IGFBP-5 and collagen alpha1(I) mRNAs by the MAPK pathway in rat intestinal smooth muscle cells [J]. Am J Physiol Gastrointest Liver Physiol, 2004, 286(5)∶G777-G783 [15] Kantarci A, Augustin P, Firatli E, et al. Apoptosis in gingival overgrowth tissues [J]. J Dent Res, 2007, 86(9)∶888-892 [16] Mitic K, Popovska M, Pandilova M, et al. The role of inflammation and apoptosis in cyclosporine A-induced gingival overgrowth [J]. Bosn J Basic Med Sci, 2013, 13(1)∶14-20 [17] Livada R, Shiloah J. Calcium channel blocker-induced gingival enlargement [J]. J Hum Hypertens, 2014, 28(1)∶10-14 [18] Sousa CP, Navarro CM, Sposto MR. Clinical assessment of nifedipine-induced gingival overgrowth in a group of brazilian patients [J]. ISRN Dent, 2011, 2011∶102047 [19] 刘海杰,潘亚萍.牙周致病微生物与药物性牙龈肥大的关系[J].口腔医学研究,2015,31(4)∶370-376 [20] Johnson RB, Zebrowski EJ, Dai X. Synergistic enhancement of collagenous protein synthesis by human gingival fibroblasts exposed to nifedipine and interleukin-1-beta in vitro [J]. J Oral Pathol Med, 2000, 29(1)∶8-12 [21] Seymour RA, Ellis JS, Thomason JM. Risk factors for drug-induced gingival overgrowth [J]. J Clin Periodontol, 2000, 27(4)∶217-223 [22] Subramani T, Dhanaraj L, Senthilkumar K, et al. Expression of TNF-alpha and RANTES in drug-induced human gingival overgrowth [J]. Indian J Pharmacol, 2010, 42(3)∶174-177 [23] Charles N, Ramesh V, Babu KS, et al. Gene polymorphism in amlodipine induced gingival hyperplasia: a case report [J]. J Young Pharm, 2012, 4(4)∶287-289 [24] Dannewitz B, Kruck EM, Staehle HJ, et al. Cyclosporine-induced gingival overgrowth correlates with NFAT-regulated gene expression: a pilot study [J]. J Clin Periodontol, 2011, 38(11)∶984-991 [25] Babu SP, Ramesh V, Samidorai A, et al. Cytochrome P450 2C9 gene polymorphism in phenytoin induced gingival enlargement: A case report [J]. J Pharm Bioallied Sci, 2013, 5(3)∶237-239 [26] Gagliano N, Costa F, Tartaglia GM, et al. Effects of aging and cyclosporin a on collagen turnover in human gingiva [J]. Open Dent J, 2009, 5(3)∶219-226 [27] Kim SS, Michelsons S, Creber K, et al. Nifedipine and phenytoin induce matrix synthesis, but not proliferation, in intact human gingival connective tissue ex vivo [J]. J Cell Commun Signal, 2015, 9(4)∶361-375 |